Literature DB >> 24024844

Beyond exon 2--the developing story of RAS mutations in colorectal cancer.

Jordan Berlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24024844     DOI: 10.1056/NEJMe1307992

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  The Peltzman effect and compensatory markers in medicine.

Authors:  Vinay Prasad; Anupam B Jena
Journal:  Healthc (Amst)       Date:  2014-09-01

Review 2.  Current biologics for treatment of biliary tract cancers.

Authors:  Diana Y Zhao; Kian-Huat Lim
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 3.  Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research.

Authors:  Checca Bakkers; Geert A A M Simkens; Ignace H J T De Hingh
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.

Authors:  Shanthi Ganesh; Xue Shui; Kevin P Craig; Martin L Koser; Girish R Chopda; Wendy A Cyr; Chengjung Lai; Henryk Dudek; Weimin Wang; Bob D Brown; Marc T Abrams
Journal:  Mol Cancer Ther       Date:  2017-12-27       Impact factor: 6.261

Review 5.  Colorectal cancer genomics and designing rational trials.

Authors:  Sebastian Mondaca; Rona Yaeger
Journal:  Ann Transl Med       Date:  2018-05

Review 6.  The Developing Story of Predictive Biomarkers in Colorectal Cancer.

Authors:  Stergios Boussios; Mehmet Akif Ozturk; Michele Moschetta; Afroditi Karathanasi; Nikolaos Zakynthinakis-Kyriakou; Konstantinos H Katsanos; Dimitrios K Christodoulou; Nicholas Pavlidis
Journal:  J Pers Med       Date:  2019-02-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.